NEW YORK (GenomeWeb News) – Hologic today named former Stryker executive Stephen MacMillan as its president and CEO, replacing Jack Cumming less than five months after Cumming returned for a second stint as head of the company.

MacMillan also was named to Hologic's board. Separately, the company also named Jonathan Christodoro and Samuel Merksamer, both of whom are managing directors at Icahn Capital, to its board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.